Skip to main content
Eric Jonasch

Oncology

Eric Jonasch, M.D.

Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Houston, TX

Dr. Eric Jonasch is a Professor in the Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, specializing in the treatment of kidney cancer and von Hippel-Lindau (VHL) disease. With over 20 years of experience, he focuses on metastatic renal cell carcinoma (RCC) and prostate cancer, with particular expertise in immunotherapy strategies and novel therapeutic combinations. Dr. Jonasch serves as Director of the VHL Clinical Center at MD Anders

...

30+

Years in Practice

Credentials

Board Certifications

  • Internal Medicine (ABIM)
  • Hematology (ABIM)
  • Medical Oncology (ABIM)
  • 2000 Medicine, Royal College of Physicians & Surgeons of Canada
  • 2000 Oncology, Royal College of Physicians & Surgeons of Canada

Education & Training

  • McGill University Faculty of Medicine — M.D., 1992
  • 1988 McGill University, Montreal, CA, Biochemistry, B.Sc
  • Royal Victoria Hospital — Residency, Internal Medicine, 1992–1995
  • New England Medical Center (Tufts Medical Center) — Fellowship, Hematology and Medical Oncology, 1995–1998
  • Beth Israel Deaconess Medical Center — Research Fellowship, 1997–1999

Peer Recognition

  • American Society of Clinical Oncology (ASCO)Conquer Cancer Foundation Merit Award

    2019

  • Castle ConnollyAmerica's Top Doctors

    2010-2025 (16 years)

  • Houston ChronicleTop Doctor

    2016-2017 (2 years)

  • MD Anderson Cancer CenterIrwin H. Krakoff Award for Excellence in Clinical Research

    2015

  • Modern Luxury Houston MagazineTop Doctor

    2022-2023 (2 years)

Recognition & Leadership

Awards & Honors

  • 2015 Irwin H. Krakoff Award for Excellence in Clinical Research, MD Anderson Cancer Center
  • 2009 Young Texans Against Cancer Research Award
  • 2008 - 2024 Renal Cell Carcinoma Translational Research, American University-Beirut
  • 1997 Molecular Biology Research Seminar for Young Investigators, American Association for Cancer Research

Clinical Focus

Subspecialties

Medical OncologyGenitourinary Oncology

Conditions & Treatments

Kidney CancerClinical Trials & Drug DevelopmentImmunotherapy

Practice Details

Hospital Affiliations

  • McGovern Medical School at UTHealth Houston
  • University of Texas MD Anderson Cancer Center

Languages

English

Experience

30+ years in practice